C2040
咳平 盐酸盐
analytical standard
别名:
氯哌斯丁
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C20H24ClNO · HCl
化学文摘社编号:
分子量:
366.32
UNSPSC Code:
41116107
PubChem Substance ID:
EC Number:
239-067-8
MDL number:
InChI key
UNPLRYRWJLTVAE-UHFFFAOYSA-N
InChI
1S/C20H24ClNO.ClH/c21-19-11-9-18(10-12-19)20(17-7-3-1-4-8-17)23-16-15-22-13-5-2-6-14-22;/h1,3-4,7-12,20H,2,5-6,13-16H2;1H
SMILES string
Cl.Clc1ccc(cc1)C(OCCN2CCCCC2)c3ccccc3
grade
analytical standard
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
application(s)
forensics and toxicology
pharmaceutical (small molecule)
veterinary
format
neat
Quality Level
Application
Cloperastine hydrochloride may be used as an analytical standard for the quantification of cloperastine in biological samples using liquid chromatography coupled to tandem mass spectrometry.
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
[Effect of cloperastine on muco-ciliary clearance].
D Olivieri et al.
Archivio Monaldi per la tisiologia e le malattie dell'apparato respiratorio, 38(5-6), 219-223 (1983-09-01)
Hao Li et al.
Journal of pharmaceutical and biomedical analysis, 51(3), 716-722 (2009-11-03)
A rapid and sensitive method based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the simultaneous quantitation of paracetamol, caffeine, pseudoephedrine, chlorpheniramine and cloperastine in human plasma has been developed and validated. After sample preparation by liquid-liquid extraction, the analytes and
Yukoh Sakata et al.
International journal of pharmaceutics, 335(1-2), 12-19 (2006-11-23)
Tablets containing both paracetamol (PM) and cloperastine hydrochloride (CLH) in a combination formulation prepared by standard vertical granulation technology were found to have altered pharmaceutical properties. The hardness and disintegration time of tablets containing both PM and CLH gradually increased
Gen Yamamoto et al.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 131(4), 523-532 (2011-04-07)
Clinically, both overactive bladder (OAB) and dysuria are known to occur in patients with cerebral infarction (CI). A few anticholinergic drugs are used to treat OAB in such patients, although the effect is not satisfactory. On the other hand, little
[Cloperastine fendizoate in the treatment of cough-producing diseases in pediatrics].
L Scotti et al.
Minerva pediatrica, 40(5), 283-286 (1988-05-01)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持